Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innovative Pharmaceutical Biotech Limited (HK:0399)
HKEX:0399
Innovative Pharmaceutical Biotech (0399) Stock Price & Analysis
0 Followers
0399 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.19 - HK$0.37
Previous CloseHK$0.21
Volume305.00K
Average Volume (3M)1.17M
Market Cap
HK$367.04M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)2.7
Beta0.13
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding1,723,193,024
10 Day Avg. Volume159,566
30 Day Avg. Volume1,172,600
Standard Deviation0.08
R-Squared0.00699
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.31
Price to Sales (P/S)392.31
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innovative Pharmaceutical Biotech News
PremiumCompany Announcements
Innovative Pharma Biotech Reports Profitable Year
PremiumCompany Announcements
Innovative Biotech’s Groundbreaking Oral Insulin
PremiumCompany Announcements
Innovative Pharma Completes Key Financial Transactions
PremiumCompany Announcements
Innovative Pharma Biotech Sets Key Board MeetingPremiumCompany Announcements
Innovative Pharma Biotech Extends Key Deadlines
PremiumCompany Announcements
Innovative Pharma Biotech’s Strategic Bond Resolutions Passed0399 FAQ
What was Innovative Pharmaceutical Biotech Limited’s price range in the past 12 months?
Innovative Pharmaceutical Biotech Limited lowest stock price was HK$0.18 and its highest was HK$0.37 in the past 12 months.
What is Innovative Pharmaceutical Biotech Limited’s market cap?
Currently, no data Available
When is Innovative Pharmaceutical Biotech Limited’s upcoming earnings report date?
Innovative Pharmaceutical Biotech Limited’s upcoming earnings report date is Nov 27, 2024 which is in 130 days.
How were Innovative Pharmaceutical Biotech Limited’s earnings last quarter?
Innovative Pharmaceutical Biotech Limited released its earnings results on Jun 28, 2024. The company reported -HK$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.052.
Is Innovative Pharmaceutical Biotech Limited overvalued?
According to Wall Street analysts Innovative Pharmaceutical Biotech Limited’s price is currently Overvalued.
Does Innovative Pharmaceutical Biotech Limited pay dividends?
Innovative Pharmaceutical Biotech Limited does not currently pay dividends.
What is Innovative Pharmaceutical Biotech Limited’s EPS estimate?
Innovative Pharmaceutical Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovative Pharmaceutical Biotech Limited have?
Innovative Pharmaceutical Biotech Limited has 1,723,193,000 shares outstanding.
What happened to Innovative Pharmaceutical Biotech Limited’s price movement after its last earnings report?
Innovative Pharmaceutical Biotech Limited reported an EPS of -HK$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Innovative Pharmaceutical Biotech Limited?
Currently, no hedge funds are holding shares in HK:0399
---
Innovative Pharmaceutical Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.07%
Trailing 12-Months
Company Description
Innovative Pharmaceutical Biotech Limited
Innovative Pharmaceutical Biotech Ltd is engaged in trading of beauty equipment and products. The company's business segments are Trading of beauty equipment and products in Hong Kong, Further, it is also involved in securities investment in Hong Kong and outside Hong Kong, and Research, development and commercialization of the oral insulin product.
---
Technical Analysis
---